Health

Results: 553-564 of 10106

PR Newswire associated0

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim

Silence Therapeutics to Participate in Three September Investor Conferences

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Croma-Pharma Introduces Electronic Instructions for Use Across the saypha® Portfolio

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree

PR Newswire associated0

NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

TESTOSTERONE AT THE MENOPAUSE

PR Newswire associated0

BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser

Vara Receives World-First CE Certification for Autonomous AI in Breast Cancer Screening